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The synapse is the essential unit of neural function. It is critical to understand how
synapses form during development, how they are maintained throughout the life of an
organism, and how their structure and function are affected by neural activity. An
understanding of these aspects of synapses will likely provide insight into the etiology of
neurodevelopmental disorders such as autism, mental retardation or epilepsy. To identify
novel regulators of synaptic development, I screened for mutants with defects in synaptic
morphology and growth at the Drosophila larval neuromuscular junction (NMJ). My
screen identified several mutants with defects in various aspects of synaptic development.
I pursued a more in depth analysis of an identified mutant, happyhour, with defects in
synaptic target selection. Synaptic target selection is critical for establishing functional
neuronal circuits. The mechanisms regulating target selection remain incompletely
understood. I describe a role for the EGF receptor and its ligand Gurken in target
selection of octopaminergic Type II neurons in the Drosophila neuromuscular system.
Mutants in happyhour, a regulator of EGFR signaling, form ectopic Type II
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neuromuscular junctions. These ectopic innervations are due to inappropriate target
selection. I demonstrate that EGFR signaling is necessary and sufficient to inhibit
synaptic target selection by these octopaminergic Type II neurons, and that the EGFR
ligand Gurken is the post-synaptic, muscle-derived repulsive cue. These results identify a
new pathway mediating cell-type and branch-specific synaptic repulsion, a novel role for
EGFR signaling in synaptic target selection, and an unexpected role for Gurken as a
muscle-secreted repulsive ligand.
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Introduction
Organisms must receive, process and respond to many streams of information at
all times. The nervous system is a complex combination of multiple cell types and
connections that have been designed for such a purpose. One of the most critical
components of this network is the connection between the cells themselves known as
synapses. Synaptic transmission is critical for every activity of the nervous system and
slight changes in synaptic properties can greatly influence nervous system function.
These synapses can change dramatically throughout the life of an organism.
Early in development there are often more synaptic connections than are necessary and
synaptic pruning will occur to refine these networks. While this pruning is taking place,
still other synapses are being maintained and often strengthened. This strengthening is
can be neuronal activity dependent and is the basis for nervous system functions like
learning and memory. In addition to these changes to existing synapses, new synapses
can be formed during the entire lifespan of an organism and in response to injury (Waites,
Craig, and Garner 2005).
Despite extensive research, the fundamental processes of learning and memory
have not been satisfactorily explained. To truly grasp these higher processes and how
neurological and psychiatric diseases disrupt these processes, it is critical to understand
neurons at their most simple functional level, the synapse. By working to understand
how synapses form, grow, and how their structure and function are modulated by
neuronal activity, we can further our understanding of the function of the brain at its most
basic level.
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Structure of the Synapse
To begin to understand complex changes in the synapse, first we must define the
structure of the chemical synapse. A chemical synapse is an asymmetric cellular junction
between neurons and their target cells, which can be other neurons, or muscles. A
synapse requires close apposition between the presynaptic terminal and the postsynaptic
terminal. The primary synapses in the central nervous system are chemical synapses,
meaning that signaling between the terminals is carried out via a chemical messenger
known as neurotransmitter, released presynaptically that binds to receptors on the
postsynaptic cell. Neurotransmitters are packaged into vesicles that cluster around an
electron dense region termed the active zone where the machinery for vesicle release is
assembled. The postsynaptic terminal contains neurotransmitter receptors, ion channels,
and other scaffolding proteins that cooperate to transduce the chemical signal. Cell
adhesion molecules help to maintain a close apposition between pre and postsynaptic
cells to ensure efficient transmission of the neurotransmitter signal.

Drosophila larval Neuromuscular Junction as a Model Synapse
In the mid-1970s the Drosophila larval NMJ was first described as a potential
model system to study synaptic development (L. Y. Jan and Jan 1976). The ultimate goal
of many neuroscientists is to gain understanding of central synapses in humans. To reach
this goal, a model with molecular simplicity, accessibility and genetic flexibility would
be a great tool. Drosophila has become a valuable model for studying synaptic
development and it has been shown that vertebrate homologs of fly genes often exhibit
comparable function in the vertebrate system.
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The NMJ is the junction of the axon terminal of a motoneuron that projects from
the ventral nerve cord and makes contact with the body wall muscle membrane. The
nerve terminal contacting the muscle develops specialized varicosities called boutons that
contain hundreds of individual synapses (Atwood, Govind, and Wu 1993). These boutons
are enveloped by a post-synaptic specialization, the subsynaptic reticulum. The
subsynaptic reticulum consists of membrane folds surrounding the boutons, and is
believed to be the site of clustered postsynaptic receptors (Lahey et al. 1994). In the past,
studies have referred to this entire nerve terminal as a synapse. It is more common to
refer to this entire structure as the nerve terminal or the NMJ and individual pairings of
presynaptic release machinery and postsynaptic receptor clusters as synapses.
Drosophila has an extensive history as a genetic organism, and as a consequence,
a well-stocked genetic toolbox to identify molecular components of synaptic
development. Forward genetic screens facilitate identification of genes responsible for a
phenotype of interest. The function of genes can be tested via reverse genetic techniques
such as RNAi or dominant negative transgenes. The Gal4/UAS system refines such
techniques by providing tissue specific expression of transgenes that can modulate a
gene’s function (Brand and Perrimon 1993). This tool allows study of essential genes.
Tissue specific Gal4 drivers allow the study of synaptic function of a gene separately in
the neuron or muscle. Also of great value is the large collection of readily available
mutants to facilitate testing for genetic interactions.
The Drosophila 3rd instar larva is composed of repeating segments each with a
stereotyped pattern of muscles and innervations of those muscles (Lahey et al. 1994).
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This strict patterning and repetition allows us to quantify subtle changes in the
development of this pattern and also increases the power of our observations by
providing a larger number of sample NMJs in each individual larva (Bate and Broadie
1995). The Drosophila NMJ is a glutamatergic innervation similar to those found in the
mammalian central nervous system. The NMJ shows developmental and activity
dependent plasticity, which is also similar to mammalian synapses.
There are four types of motoneurons that innervate the Drosophila body wall
musculature: Type Ib, Is, II and III (Prokop 2006). The Type Ib and Is motoneurons are
glutamatergic and responsible for muscle contraction. Type II motoneurons are
octopaminergic and perform a neuromodulatory role. Type III neurons secrete insulinlike peptide and sparsely innervate the body wall. Each of these neurons forms synapses
with body wall muscle cells. The Type I motoneurons are the most well studied. My
work is focused on the Type II neurons.
Type II octopaminergic motoneurons have long been observed but relatively little
has been done to uncover the physiological role of these neurons. Initially, octopamine
was known to function as a neurotransmitter/modulator/hormone with a number of
functions in other invertebrates. For example, octopamine can participate in
neuromodulation of the escape response of crayfish, and excitatory modulation of
somatic and visceral muscles. Immunohistochemistry revealed that octopamine was
localized to a number of specific areas (midline of ventral ganglion, peripheral fibers that
innervate most of the body wall muscles) in Drosophila larvae (Monastirioti et al. 1995).
These Type II neurons can be labeled with several specific reagents: SSB antibody
(Budnik and Gorczyca 1992), Octopamine antibody (Monastirioti et al. 1995), Vesicular
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Monoamine Transporter (necessary to package octopamine into synaptic vesicles)
antibody (Greer et al. 2005), Tyrosine Beta-Hydroxylase (enzyme necessary to produce
octopamine) antibody (Koon et al. 2011) as well as the Tyrosine Decarboxylase-2 Gal4
line (Tdc2-Gal4) which expresses specifically in these Type II neurons.
The role of these neurons in Drosophila is still being established. Recent work has
established a role for these neurons in synaptic and behavioral plasticity. Octopamine is
known to play a role in appetitive behaviors and locomotion. Upon starvation,
Drosophila larvae exhibit an increased rate of locomotion that may be modulated by
Type II octopaminergic synapses. These larval Type II innervations generate dynamic
filopodia like extensions in response to the starvation stimulus. This change in
locomotive behavior requires these octopaminergic neurons (Koon et al. 2011). This
represents a situation in which Type II neurons are modulating both synaptic and
behavioral plasticity to a given stimulus. Both Type I and Type II NMJs express
octopamine receptors on their surface and both respond to octopamine with synaptic
growth. This is yet another mechanism by which Type II neurons can influence synaptic
plasticity.

Guidance and Target Selection of Larval Motoneurons
All motoneurons begin development as neuronal cell bodies in the ventral cord.
These neurons must extend an axon out of the ventral nerve cord and project to the
posterior of the animal. These axons encounter a large number of guidance molecules
from their initial exit from the ventral nerve cord until they reach their specific muscle
target. This whole process takes only 6 hours from the first extension of the axons until
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functional NMJs are formed (J. Johansen, Halpern, and Keshishian 1989). Some
examples of known guidance molecules include netrins and their receptors DCC or Unc5,
slits and their receptor robo, ephrins and eph receptors, semaphorins and plexins. Most of
these molecules can act as attractants or repellants depending on the context and the
expression of receptors. In addition to these major guidance players there are several
other known factors that influence axon guidance, developmental morphogens such as
BMP, Wnt, hedgehog and FGF. Lastly, extracellular matrix proteins and adhesion
molecules can play a large role in guiding the extending growth cones by providing
permissive or non-permissive substrates for innervation.
Once axons utilize a complement of these pathways to extend to the proper
segement and approach their target muscle field, another more specific type of guidance
must occur to provide synaptic specificity. These axons must specifically choose their
synaptic partners reproduceably and specifically direct synapse formation onto
subcellular compartments of their synaptic partners. One mode of target selection is
mutual attractive recognition through cell adhesion or cell surface molecules. This mode
of target identification involves direct recognition and homotypic interactions between
cell adhesion molecules on the extending neuron and it’s target. In drosophila,
neurexin/neuroligin, Eph/ephrin, and SynCAM are capable of inducing specific synaptic
connections.
In addition to attractive cues, there are also repulsive cues to refine synaptic target
selections. While there are significantly fewer of these pathways delineated, repulsive
guidance is an important complement to the attractive pathways. One example of this in
Drosophila is Wnt4. In the drosophila body wall there are two neighboring muscles M12
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and M13 which are innervated by MN12s and RP1/4 neurons, respectively. Wnt4 is
expressed by M13 muscles but not M12 muscles. Wnt4 loss of function mutants exhibit
inappropriate synapse formation of MN12s neurons onto M13 muscles and ectopic
expression of Wnt4 in M12 muscle inhibited MN12s neuron synapses (Inaki et al. 2007).
This repulsive pathway acts in conjunction with attractive cues to refine synaptic
specificity between two adjacent muscle fibers.
Gradients of cues can guide axons outward to their target muscle field but they
can also play a role in generating synaptic specificity. In drosophila, olfactory receptor
neurons (ORNs) that express a specific olfactory receptor all project their axons to the
same glomerulus in the brain. Projection neurons (PNs), the postsynaptic partners of
ORNs, independently project their dendrites in a spatially defined map to the antennal
lobe before the ORNs innervate those areas. Graded expression of Semaphorin1a by the
PNs is necessary for proper dendritic targeting of the ORN projections (Komiyama et al.
2007).
One last example of synaptic specificity control involves control at the level of
transcription. At the Drosophila NMJ, the transcription factor Tey regulates synaptic
specificity by repressing the expression of repulsive cell surface molecule Toll (Inaki et
al. 2010). Tey is specifically expressed in M12 muscles but not M13 muscles resulting in
the down-regulation of Toll expression in M12 muscles but not M13 muscles. Loss of
Tey leads to upregulation of Toll on M12 and inhibition of synapse formation.
Conversely, misexpression of Tey in M13 causes ectopic innervation on M13 muscles.
There are a number of converging pathways that govern synaptic specificity and within
these pathways are a number of mechanisms critical for providing such specificity.
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Synaptic Components
A chemical synapse comprises pre-synaptic and post-synaptic components. Presynaptically, neurotransmitter-filled vesicles cluster at and are released from
specializations called active zones (Inaki et al. 2007). This specialization involves the
clustering of several different proteins, which contribute to the calcium-dependent fusion
of the synaptic vesicles (Fejtova and Gundelfinger 2006). These active zones must have
post-synaptic clusters directly opposite in order to maintain the fidelity of signaling. This
very coordinated and precise apposition of active zone and post-synaptic receptor clusters
is essential for rapid and efficient synaptic transmission and determines the efficacy of
the particular synapse (R J Kittel, Hallermann, et al. 2006).
Each of the individual synapses at the synaptic terminals of the NMJ contains a
presynaptic release site referred to as the active zone. Two known proteins present at the
pre-synaptic active zone in Drosophila synapses are Bruchpilot (Brp) and Cacophony
(Cac). Brp is a member of the ERC/CAST family of proteins, which localizes to the
active zones of various synapses and binds to other active zone proteins (DeguchiTawarada et al. 2004; Ko et al. 2008; Ohtsuka et al. 2002; Y. Wang et al. 2002).
Additionally, Brp is a direct component of the T-bar (Fouquet et al. 2009), an electron
dense structure that may be associated with increased release probability at the active
zone.
One of the primary components of the post-synaptic density is the glutamate
receptor subunit DGluRIII (Marrus et al. 2004), a necessary subunit of the glutamate
receptor complex. In cases of limiting DGluRIII levels, these receptors cluster
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preferentially opposite the largest active zones, which have a higher release probability
(Marrus and DiAntonio 2004). This supports a model of activity dependent correlation
between the post-synaptic density and the size of the apposed active zone. It is possible
that neurotransmitter release promotes the clustering of DGluRIII, and that active zones
with higher release probability accumulate more DGluRIII. Alternatively, there could be
a retrograde specification of presynaptic release properties.
A large number of genes are necessary to regulate and influence the process of a
neuron extending its axon and growing toward its specific target and subsequently
forming a functional synapse onto its target. Therefore, it is not surprising that there are
many mutants altered synaptic development in the Drosophila larvae. The following
portion will focus on specific genes that play a role in synaptic development.

Happyhour is a MAP4k with many functions
The gene happyhour (hppy) has recently been discovered for its role in the
ethanol response of Drosophila. When exposed to ethanol, hppy mutant flies are resistant
to intoxication (Corl et al. 2009). Hppy is predicted to encode protein with an N-terminal
serine/threonine kinase domain and a C-terminal citron-homology domain. The closest
mammalian homologs of Hppy are members of the Germinal Center Kinase-1 (GCK-1)
family of Ste20-related kinases, including GLK (Germinal Center-like Kinase) and GCK
itself (Dan, Watanabe, and Kusumi 2001; Findlay et al. 2007). GCK-1 family members
have been shown to act as mitogen-activated protein kinases (MAPKs) upstream of the
Jun N-terminal kinase (JNK) signaling pathway (Chen and Tan 1999). Hppy has also
been shown to be a pro-apoptotic kinase through its activation of JNK (Lam et al. 2010).
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While generally it is know that hppy is a MAP4K, there is still very little known about
this kinase and its role in vivo.

Epidermal Growth Factor Recptor (EGFR)- a molecule with many roles throughout
development
The Drosophila EGFR is the single member of the EGFR/ErbB family in the fly
genome and is very similar to mammalian ErbB family members in its structure.
Extracellularly, it has the typical four domains including two cysteine-rich domains
required for ligand binding. There are at least 30 known roles for EGFR signaling during
drosophila development (Shilo 2003). These roles range from early embryogenesis and
patterning to much later patterning in the nervous system and appendages.
In order to regulate such diverse signaling events, EGFR has five different
ligands, four activating and one inhibitory. Three of the ligands, Spitz, Keren and Gurken
are produced as transmembrane precursors. The primary activating ligand is Spitz which
is responsible for activation in most tissues (Rutledge et al. 1992). The activated form of
Spitz is produced by tightly regulated cleavage of the membrane bound precursor
(Schweitzer et al. 1995). A ligand, Keren,that is structurally related to Spitz has recently
been identified (Reich and Shilo 2002; Sinisa Urban, Lee, and Freeman 2002). A fourth
activating ligand, Vein, is a secreted ligand that has an inherently weaker activation
capacity than the other 3 activating ligands (Schnepp et al. 1996). In some tissues, Vein
functions as the main ligand; for example, Vein induces muscle cell attachment fate
(Yarnitzky, Min, and Volk 1997). It can also be used as positive feedback reinforcement
to initial activation of EGFR by another ligand. Lastly, Argos functions as a secreted
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ligand that binds the receptor but inhibits activation by competing with the activating
ligands (M Freeman et al. 1992). It is induced in response to activation of the EGFR and
plays a major role in restricting the activation range of the activating ligands (Golembo et
al. 1996).
Ligand processing is a key regulatory step in EGFR signaling regulation. This
processing has been shown to modify the Spitz ligand and was subsequently found to also
be valid for processing the other membrane tethered ligands. Spitz is produced as an
inactive membrane precursor and is ubiquitously expressed (Schweitzer et al. 1995). It
has a relatively high turnover rate in order to prevent nonspecific cleavage from taking
place within the cell (J R Lee et al. 2001). The regulation of Spitz processing was further
informed upon finding mutations in two genes that give rise to similar phenotypes as loss
of function of spitz. These genes are Star and rhomboid (Mayer and Nüsslein-Volhard
1988). Star regulates the trafficking of Spitz from the endoplasmic reticulum to the Golgi
compartment though its function as a type II transmembrane protein that functions as a
cargo receptor for Spitz (Kolodkin et al. 1994).
The second gene responsible for ligand processing of Spitz, Keren, and Gurken is
rhomboid. Rhomboid is a seven-transmembrane protein that functions as the protease for
Spitz cleavage (S Urban, Lee, and Freeman 2001). The catalytic domain of Rhomboid is
within its conserved transmembrane domains which leads to regulated intramembrane
proteolysis (Brown et al. 2000). This cleavage takes places within the Golgi rather than
on the plasma membrane. Rhomboid expression is extremely dynamic and synonymous
with EGFR activation (Golembo, Raz, and Shilo 1996; Sturtevant, Roark, and Bier
1993). Expression of Rhomboid is the limiting step in EGFR activation.
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EGFR appears to provide a relatively short-range signaling pathway between
cells. It also can occasionally participate in some short range signaling several cells away
from the source. In most cases, activation of EGFR serves as a binary switch either in the
adjacent cells or the ligand secreting cell itself. There are three identified negative
feedback circuits that have been identified to be critical to maintaining this tight
restriction of EGFR activation. As mentioned previously, the Argos ligand is a
component of the negative feedback that is induced upon ligand binding. Argos is
induced in the cells receiving high levels of EGFR ligand and can exert influence up to
several cells away from the source (Golembo et al. 1996). Argos acts as a competitive
inhibitory ligand on the source cell and on cells further away. The distribution profiles of
the activating ligand and Argos are likely inverse, with activating ligand highest at the
source cell and Argos highest several cells away maintaining this refined EGFR
activation.
The other feedback circuits are cell autonomous and less universally used than
Argos. Kekkon is a transmembrane protein that binds EGFR and prevents receptor
dimerization and consequently, activation of EGFR (Ghiglione et al. 1999). Sprouty is an
intracellular protein that can interfere with EGFR signaling at several levels (Casci,
Vinós, and Freeman 1999). Sprouty interacts with signaling elements that are shared by
other receptor tyrosine kinases. Sprouty activity can therefore disrupt the function of
multiple signaling pathways. The inhibitors Yan and DCbl are not transcriptional targets
of EGFR and are not activated in response to EGFR signaling. Yan competes with
Pointed which is a transcription factor that is triggered by EGFR activation preventing
activation of negative feedback via Argos, and activation of other genes (Gabay et al.
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1996). DCbl exacts its inhibition by facilitating endocytosis of the EGFR and subsequent
degradation (Pai, Barcelo, and Schüpbach 2000).
The main intracellular signaling pathway activated by EGFR is the Ras/MAPK
pathway. Mutations in the intracellular components of the Ras/MAPK pathway
phenocopy loss of EGFR or ligands (Diaz-Benjumea and Hafen 1994). Activated Ras can
mimic EGFR gain of function phenotypes (Brand and Perrimon 1994). However, there is
an exception to Ras/MAPK activation being the only output of the EGFR. In most cases,
transcriptional activation based on the average of EGFR activation around the cell is the
final read out. In cases of cell migration, the location of the receptor that has been
activated is critical and the final response is likely to be local rather than transcriptional
(Duchek et al. 2001). This suggests that in the case of cell migration EGFR is acting
through a different yet unknown signaling pathway.

Gurken is a regulator of oocyte development
A homolog of transforming growth factor-alpha (TGF-alpha) encoded by the
gurken gene can initiate polarity along both the dorsal ventral axis and the anterior
posterior body axis (González-Reyes, Elliott, and St Johnston 1995; Roth et al. 1995).
Briefly, in midoogenesis the nucleus of the oocyte is positioned posteriorly and produces
the gurken signal that activates a program in the nearest follicle cells by activating the
EGFR receptor torpedo, that instructs them to acquire a posterior fate. These posterior
cells then signal back to the oocyte to induce polarization of the oocyte’s anteriorposterior axis. Later, the oocyte nucleus moves to an anterior corner of the oocyte and
again produces a gurken signal that activates the nearest follicle cells via EGFR and they
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take on a dorsal identity. These dual roles of Gurken were quite surprising as many
developmental biologists at the time assumed that each of the axes were determined by
separate signaling pathways and the specification was not interdependent. Gurken is
tightly regulated at several levels including localized transcription as well as regulatory
sequences that restrict gurken mRNA localization and concentration of Gurken protein.
Gurken has only been shown to be localized to the developing oocyte and a role for
Gurken outside the oocyte has never been described.

Summary
While many studies have examined various regulators of synaptic development,
the full repertoire of processes responsible have not yet been discovered. In the following
chapters, I perform a forward genetic screen to identify novel regulators of synaptic
development. I characterize the role of EGFR signaling in regulating synaptic target
selection of Type II neurons via its ligand Gurken. These findings have contributed to our
understanding the pathways involved in synaptic target selection and have highlighted an
unusual and unexpected role for Gurken in this process. In addition, this work has laid the
foundation for future studies by identifying other genes that also play an important role in
synaptic development.
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Chapter 2

Genetic Analysis of Synaptic Development

SAN directed and performed the majority of this work. SAN was assisted by Dominic
Berns on the screen.
A portion of this work appears in the manuscript:
Valakh, V., Naylor, S.A., Berns, D.S., DiAntonio, A. Large-scale RNAi screen reveals
novel regulators of synapse development. Developmental Biology: In Revision
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Abstract
The synapse is the essential unit of neural function. It is critical to understand how
synapses form during development and are maintained throughout the life of an organism
as well as how their structure and function are affected by neural activity. An
understanding of these underpinnings of synapse development will provide insight into
the etiology of neurodevelopmental disorders such as mental retardation or epilepsy. In
order to uncover these mechanisms, I undertook a forward genetic screening approach to
identify mutants with defects in synaptic development. I took advantage of the tight
apposition between presynaptic release machinery and postsynaptic receptors and stained
for markers of each of these structures, Bruchpilot and DGluRIII respectively. These
markers allow examination of a number of phenotypes in addition to synaptic apposition.
We utilized these antibodies to screen several collections of mutants including EMS
mutants, piggyBac insertional mutants and transgenic RNAi lines. From these lines I
have performed further analysis on three independent mutants. piggyBac insertional
mutant 141-604 was found to have a defect in synaptic apposition. With genetic analysis,
I was able to confirm that this phenotype was due to a second site mutation in the
bruchpilot gene. I also performed genetic mapping on an EMS-induced mutation
provisionally named MA3.5 which exhibited extensive axonal clogs of Bruchpilot
protein. I found that this phenotype is due to a mutation in Beta-Spectrin. Lastly, I have
characterized a hit from the RNAi screen, happyhour, in more detail. This analysis of
happyhour is the focus of Chapter 3.
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Introduction
A chemical synapse is composed of pre-synaptic and post-synaptic components.
Pre-synaptically, neurotransmitter-filled vesicles cluster at and are released from
specializations called active zones (Chen and Tan 1999). This specialization involves the
clustering of several different proteins, which contribute to the calcium-dependent fusion
of the synaptic vesicles (Fejtova and Gundelfinger 2006). These active zones must
directly oppose post-synaptic clusters in order to maintain the fidelity of the signal. This
very coordinated and precise apposition of active zone and post-synaptic receptor clusters
is essential for rapid and efficient synaptic transmission and determines the efficacy of
the particular synapse (R J Kittel, Hallermann, et al. 2006). To uncover what genes are
necessary to establish and maintain this apposition, we undertook a forward genetic
screen.
Our forward genetic screen used the easily accessible and genetically malleable
Drosophila melanogaster NMJ. Terminals called boutons contain hundreds of individual
synapses (Atwood, Govind, and Wu 1993). The Drosophila 3rd instar larva is composed
of repeating segments each with a stereotyped pattern of muscles and innervations of
those muscles (Collins and DiAntonio 2007). This strict patterning and repetition allows
us to quantify subtle changes in the development of this pattern and also increases the
power of our observations by providing a larger number of sample neuromuscular
junctions (NMJs) in individual larvae (Bate and Broadie 1995).
Each of the individual synapses at the synaptic terminals of the NMJ contains a
presynaptic release site referred to as the active zone. Two known proteins present at the
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pre-synaptic active zone in Drosophila synapses are Bruchpilot (Brp) and Cacophony
(Cac). Brp is a member of the ERC/CAST family of proteins, which in other organisms
including drosophila has been shown to localize to the active zones of various synapses
and to bind to other active zone (Deguchi-Tawarada et al. 2004; Ko et al. 2008; Ohtsuka
et al. 2002; Y. Wang et al. 2002). Brp is a direct component of the T-bar (Fouquet et al.
2009), an electron dense structure that may be associated with increased release
probability at the active zone. One of the primary components of the post-synaptic
density is the essential glutamate receptor subunit DGluRIII (Marrus et al. 2004). The
schematic in Figure 2.1A illustrates the spatial relationship between these two proteins.
The precision of apposition can be exploited in mutagenesis screens to identify
molecules involved in active zone assembly and synaptic development. Previously, the
lab performed a forward genetic screen using a library of p-element insertional mutants to
look for mutants that disrupt the synaptic alignment. These screens were performed by
staining individual mutant lines with an antibodies specific to Brp and DGluRIII and
examining the larvae for any defects in expression (Figure 2.1B). These screens were
successful in identifying several different genes critical to synapse development (Wairkar
et al. 2008; Wairkar et al. 2009; Graf et al. 2009). While these previous screens did
identify some critical and previously unknown contributors to active zone alignment, they
have been limited by technical restrictions. One limiting factor is the insertional mutant
library itself. P-elements have an insertion preference near the 5’ end of genes, which
limits the number of genes that are actually disrupted by the insertion. Additionally, the
P-element collection has not reached saturation on the second and third chromosomes.
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A new library of insertional mutants
To address these deficiencies in the P-element collection, a new collection of
insertional mutants has been made by the Luo lab at Stanford (Schuldiner et al. 2008).
This library takes advantage of a different transposable element, the piggyBac. The
piggyBac transposon was originally isolated from the cabbage looper moth. This element
acts similarly to a P-element in that in the presence of its transposase it is able to move
about within the genome. Differing from P-elements, these piggyBac insertions excise
cleanly and do not have the same insertion preference for the 5’ end of genes. The Luo
lab has created a modified version of the piggyBac transposon that has been altered to
enhance its mutagenic capabilities. This version contains splice acceptors followed by
stop codons in all three frames and in both orientations of the transposon. This will
enhance mutagenicity by splicing into transcripts and terminating them rather than by
inserting lengthy sequence. It also carries a marker, DsRed, driven by an eye promoter
(3XP3) to provide an easily visualized live marker of the transposon.

EMS and RNAi knockdown as additional screening tools
In addition to these pBac mutants, I also generated a collection of EMS mutants to
screen for synaptic development defects. EMS creates random point mutations
throughout the genome. These EMS mutations provide a set of mutants that are
divergent from other insertional mutants that have insertional bias. I’ve also taken
advantage of the collection of RNAi transgenic flies from the VDRC stock center. I
screened a specific collection of RNAi lines, by expressing the RNAi and Dicer2 (known
to enhance the efficacy of RNAi knockdown) specifically in post-mitotic neurons using
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the ElavGal4 driver. These lines allowed me to test genes that might have caused severe
developmental defects if disrupted in the entire animal.
These three collections of mutants provide a new and untapped resource to
uncover mutations that disrupt the establishment and maintenance of the active zone and
post-synaptic density in Drosophila. By adapting a screen that has proven fruitful in
other mutant collections, I have been able to uncover a collection of new mutants critical
to the active zone and its apposition to the post-synaptic density. It is likely that multiple
signaling pathways may be involved in this complex process and this collection may
provide means to uncover their roles. There are likely a great number of proteins
involved in these processes and so far only a handful have been found and examined,
suggesting that there are a great number left to be found. By delineating the pathways
involved in establishing the active zone and guiding synaptic development, we are
enabling ourselves to more clearly identify situations where the synapse is improperly
formed or functioning, which may be a leading cause of neurodevelopmental
dysfunction. This will begin to uncover how we think, learn and remember throughout
our lives.

Materials and Methods
Fly Stocks
Flies were maintained at 25°C on standard fly food. Wild type (WT) flies were Canton S
(CS) unless specified otherwise. The following flies were obtained from the Bloomington
StockCenter: w118; P{hs-hid}2, wgSp-1/Cyo, w118; P{hs-hid}3, Dr1/TM6B, Tb1, al[1]
dp[ov1] b[1] pr[1] c[1] px[1] sp[1], y[1]cv[1]v[1]f[1]car[1], t[1]v[1]m[74f]f[1]. The
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pBac collection was supplied by the Kyoto Drosophila Genome Resource Center
(DGRC) who maintains the pBac insertional library made by the Luo Lab. The collection
of KK RNAi lines were supplied by the Vienna DGRC.
Immunohistochemistry
Third-instar larvae were dissected in PBS and fixed in either Bouin’s fixative for 5 min. at
room temperature (RT) or for 30 min on ice. Larvae were washed with PBS containing
0.1% Triton-X-100 (PBT) and blocked in 1% NGS in PBT for 30 min. This was followed
by overnight incubation in primary antibodies in 1% NGS in PBT and three washes in
PBT. Washes were followed by incubation in secondary antibodies in 1% NGS in PBT
for 45 min, three final washes in PBT, and equilibration in 70% glycerol in PBS. Samples
were mounted in Vectashield (Vector, Burlingame,CA). The following primary antibodies
were used: mouse anti-nc82 (Brp) (Wagh et al. 2006) 1:250, rabbit anti-DGluRIII
(Marrus et al. 2004) 1:2500, rabbit anti-Pak 1:2000. Goat Cy3- and FITC conjugated
secondary antibodies against mouse and rabbit IgG were used at 1:1000 and were obtained
from Jackson ImmunoResearch. Antibodies obtained from the Developmental Studies
Hybridoma Bank were developed under the auspices of the National Institute of Child
Health and Human Development and maintained by the Department of Biological
Sciences of the University of Iowa, Iowa City, IA.

Imaging and Analysis
Samples were imaged with a Nikon D-Eclipse C1 confocal microscope using 60X oil
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objective. Shown images are z projections of confocal stacks acquired from serial laser
scanning.

Results and Discussion
In order to identify new pathways involved in synaptic development and synaptic
apposition, we performed a forward genetic screen on a library of piggy-Bac insertional
mutants. We dissected third-instar larvae from each line and stained for a marker of the
presynaptic active zone Bruchpilot (Brp) (Wagh et al. 2006) and the essential glutamate
receptor subunit DGluRIII (Marrus and DiAntonio 2004). We identified lines with
defects in synaptic development including axon transport defects, synaptic targeting
defects, active zone defects, and NMJ morphology defects.
The pBac library included 1795 independent insertion lines. Of these lines, 344
exhibited larval lethality and were therefore not screened for synapse defects. 22 lines
were found to have a synapse relevant phenotype in a number of categories. These
categories are listed in Table 1.
Synaptic Apposition, Active Zone number-1
Overall Size of NMJ - 5
Bouton Size, Number, or Shape - 5
Axon Transport - 4
Axon Structure and Ventral Nerve Cord - 3
Other - 4

Table 1. Phenotypic categories
of hits from piggyBac screen.
Numbers indicate individual
mutant lines exhibiting that
phenotype

Of these mutants, we chose the mutant 141-604 from the category “Synaptic Apposition,
Active Zone number” to investigate further. We chose this mutant because it has a
synaptic apposition and active zone phenotype without any general defect of the NMJ
(Figure2.2A). The phenotype is specific to active zone development and less likely to be
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due to a developmental defect. The other categories of mutants have more general
overall defects and may be due to genes that are involved in general development rather
than specific to active zone development.
We found 141-604 due to a decrease in overall Brp levels as well as a decrease in
the number of Brp puncta. In addition to this phenotype, the DGluRIII staining is more
diffuse in mutants. We quantified several aspects of these phenotypes. We found
significant changes in three categories of measurement (density of Brp puncta per
DGluRIII area, average area of Brp puncta, average intensity of Brp puncta Figure2.2BD). Due to the decrease in Brp puncta number we observed a defect in synaptic
apposition in which DGluRIII clusters were unapposed by presynaptic Brp. To determine
whether this defect is truly a defect in apposition and not a consequence of the change in
DGluRIII localization we described, we examined a second postsynaptic marker. The
kinase Pak is also a marker of the postsynaptic density. We also found a defect in
apposition between Brp and Pak (Figure2.3A,B) this indicates that the apposition defect
is not a consequence of a change in glutamate receptors.
A defect in apposition can lead to defects in synaptic transmission. To test
whether 141-604 exhibits a defect in synaptic transmission we performed
electrophysiological recordings. Miniature excitatory junction potentials (mEJPs) and
evoked responses were examined, Figure 2.4 A&B are representative mEJP traces. 141604 homozygous larvae have an increased frequency and amplitude of mEJPs. In Figure
2.4C I have grouped mEJPs into bins by their amplitude. There is a shift toward mEJPs
with a larger amplitude. The evoked response of 141-604 mutants was comparable to
wildtype (data not shown). Together, these data indicate that there is a decrease in quantal

23

content (p=.01). Quantal content is the measure of the number of vesicles released per
stimulation event (Figure 2.4D). This significant decrease in quantal content and
increased mEJP amplitude suggests that there may be changes on both the pre-synaptic
and post-synaptic sides or that there may be larger synaptic vesicles released. In addition
to the previous recordings, we also tested the mutant for paired pulse facilitation by
delivering two subsequent stimuli with a short inter-stimuli period. A test for paired
pulse facilitation would measures whether there is an increased probability of release
upon consecutive stimuli as observed in wild-type. If the mutant has a higher response
than wild-type to the second stimuli, we can conclude that the release probability in the
mutant is lower than wild-type. Conversely, if we find the second response to be smaller
in amplitude, we can conclude that the release probability is higher in the mutant than
wild-type and we are seeing vesicle depletion in the decreased second response. We
found the facilitation response to be comparable to wildtype indicating that the presynaptic release probability is normal. The decrease in number of vesicles released and
the normal release probability is consistent with the anatomical data of decreased number
and intensity of Brp puncta. Fewer Brp puncta indicates that there are fewer sites with a
high release probability correlating with the decrease in number of vesicles released.
This electrophysiology differs from the Brp mutant where the evoked amplitude is
significantly decreased and the QC is decreased by ~80% (Kittel, Wichmann, et al.
2006). However, Kittel et al. have not addressed the probability of release in the Brp
mutant.
Stock 141-604 has a putative piggyBac (pBac) insertion between two genes on the
second chromosome. In order to determine which gene was disrupted in 141-604 we
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undertook several approaches. We first tested several mutants in the genes surrounding
the pBac insertion. We found that the phenotype we observed in 141-604 was not due to
disruption of the genes immediately adjacent to the pBac insertion site. It is possible that
this pBAc insertion line also carries a second site mutation that is responsible for the
active zone phenotype we observed. In order to test this possibility we allowed genetic
recombination to occur between the pBac insertion carrying chromosome and a wild-type
chromosome. If there is a second site mutation causing the phenotype, a separation
between the marked pBac insertion and the phenotype should be possible. We tested a
large number of recombinants and isolated a single recombinant chromosome lacking the
pBac insertion (termed 43) but exhibiting the observed active zone phenotype. This low
frequency of recombination between the pBac insertion and the mutation indicates that
the mutation of interest is near the pBac insertion.

Genetic mapping of allele 43
In order to gain more information about the location of the mutation I performed
recombination mapping. By calculating the recombination frequency between known
phenotypic markers and the isolated 43 chromosome, a genetic map distance between the
mutation and the given marker can be determined. I found that the recombination rate
between the phenotype and the marker artistaless (al1) was 39.8%. The recombination
rate between the phenotype and the marker plexus (px) was 37.8%. This indicates that our
phenotype is due to a mutation relatively far from the ends of the second chromosome as
these markers are close to the left and right ends of the chromosome respectively. I also

25

recorded the recombination rate between the phenotype and the marker curved (c1) which
was 18.8%.
I next begun deficiency mapping of the region (43-48) I narrowed down by
recombination mapping. Genetic deficiencies are lines carrying a defined deletion of a
particular area of a chromosome. If you generate a transheterozygote of a mutant
chromosome and the deficiency chromosome and find that it has the same or worse
phenotype as a homozygous mutant it is likely that the mutation is within that deficiency
region. I tested deficiencies in the region 43-48 on the second chromosome. I generated
transheterozygotes of the mutation and the genetic deficiencies and tested them for the
active zone phenotype. From this analysis, I determined that the mutation was in the
region 45C4-45F4. In this region there was a very obvious candidate gene to test,
bruchpilot, a component of the pre-synaptic active zone. To test whether the mutation
isolated from the 43 line was an allele of Brp, I generated a transheterozygote of the
isolated mutation and an allele of Brp (Brp69). These larvae exhibit a decrease in Brp
levels and a decrease in the number of Brp puncta observed in homozygous Brp mutants.
This data indicates that the mutation isolated from line 43 is an allele of bruchpilot
(Figure 2.5).
We decided not to pursue further study of this allele of bruchpilot for several
reasons. There are many labs specifically studying bruchpilot and its function. The goal
of the screen was to identify novel regulators of synaptic development yet to be
characterized. Therefore, I continued to pursue genetic screening and analysis of other
mutants.
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Screening of EMS mutants
In addition to screening the pBac library, we also generated a library of EMS
mutants on the third chromosome. We generated 975 individual EMS mutagenized lines.
We found that 235 of these lines carried larval lethal mutations and did not screen these
lines. We found that 126 lines were sterile. We were able to screen 612 independent
lines and found 15 with synaptic phenotypes. We did not choose any of these mutants to
pursue further as none of the phenotypes justified the time investment of genetic
mapping. We did however, carry out genetic mapping on an EMS mutant from a
previous screen in the lab.

Genetic Mapping of allele MA3.5
MA3.5 is an EMS mutant found in a previous EMS screen in the lab in which the
X chromosome was mutagenized. This mutant exhibited extensive axon transport defects
with very large accumulations of Brp occurring in the nerves (Figure 2.6). This
phenotype is very unusual. In order to determine the genetic lesion responsible for this
phenotype in MA3.5 mutants I began by performing recombination mapping. By
calculating the recombination frequency between known phenotypic markers and the
MA3.5 phenotype, a genetic map distance between the mutation in MA3.5 and the given
marker can be determined. I found that the recombination rate between MA3.5 and
markers yellow (y1 ) position 1A5 and crossveins (cv1) position 5A13 was approximately
50%. This indicates that the MA3.5 lesion is far from these two markers. I also
measured the recombination rate between MA3.5 and forked (f1) position 15F4-15F7,
which was approximately 4.4%. This indicates that MA3.5 is close to the forked locus.

27

From this recombination data, I narrowed down a region to test with genetic deficiencies,
14B-17F.
To determine the identity of the gene mutated in MA3.5 I generated
transheterozygotes with several overlapping deficiencies covering the area of interest I
identified with recombination mapping. Combining MA3.5 with a deficiency in the same
region resulted in lethality. Using this lethality I was able to reduce my region of interest
to between16B10 and 16C1. Within this region, there were 11 genes. One gene in
particular, Beta-Spectrin, seemed a likely candidate to be the gene mutated in MA3.5. To
test whether the lesion in MA3.5 is a mutation in Beta-Spectrin I generated a
transheterozygote of MA3.5 and an allele of Beta-Spectrin. Trans-heterozygous larvae
exhibited an interesting phenotype. These larvae’s tails were flipped upward while they
were in culture. This tail flip phenotype is associated with axon transport defects (Hurd
and Saxton 1996). These transheterozygotes also exhibited the same axon transport
phenotype as MA3.5 heterozygotes. Together, this data suggests that MA3.5 is an allele
of Beta-Spectrin.
We decided not to pursue further analysis of this allele of Beta-Spectrin. BetaSpectrin has been well studied in synaptic development in Drosophila. Recently,
overexpression of Beta-Spectrin alleles known to cause symptoms in human patients
results in severe axon transport defects very similar to what we observed in the BetaSpectrin allele MA3.5 (Lorenzo et al. 2010). Having no other novel phenotypes to
explore, we proceeded to screen with an RNAi collection.
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Screening a subset of the Vienna RNAi collection
In addition to the screens already described, we also performed our Brp/DGluRIII
staining screen on a collection of transgenic RNAi lines acquired from the Vienna
DGRC. This collection consists of 500 independent transgenic lines whose target genes
include neuron in their gene ontology description. This collection also features a
common insertion site for every RNAi transgene. This single insertion site can help
control for expression level effects often observed when transgenes are inserted in
various places in the genome. To examine the effect of knockdown of these genes in
neurons, I expressed these RNAi transgenes under the control of the post-mitotic panneuronal driver Elav-gal4. In addition to expressing the RNAi construct I also expressed
the gene Dicer-2 known to enhance the efficiency of RNAi processing.
From this collection, I found 40 lines that exhibited a synaptic phenotype when
the RNAi was expressed in neurons. To test whether the phenotype is specifically caused
by RNAi knockdown of that particular gene, we acquired mutants of as many of the 40
hits as possible. We have been able to confirm several of these RNAi hits with true
mutations of the gene. Many of the RNAi lines were isolated as having a phenotype of
synaptic retraction. Synaptic retraction is a condition where a branch or an entire presynaptic neuron has disassembled leaving behind a post-synaptic “footprint” as the postsynaptic clusters disassemble much more slowly than the pre-synapse. We found that
none of the genes suspected to have retractions actually exhibited retractions in the
mutant lines. This is an example of one of the caveats of working with RNAi knockdown.
There is a potential for spurious phenotypes due to off target effects of the RNAi or
general effects of the genetic background of these transgenic flies.
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From this collection of confirmed RNAi hits we elected to pursue further study of
the gene happyhour. These studies are detailed in Chapter 3.
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Figure 2.1. Bruchpilot (BRP) and DGLuRIII are tightly apposed at
synapses in the Drosophila NMJ
A) Images of 3rd instar larval muscle 4 NMJ immunolabeled with anti Brp
(red) and anti-DGluRIII (green)
B) Schematic of a single active zone. The presynaptic release machinery
is labeled by Brucpilot (Brp) staining indicated by the red circle. This active
zone actively clusters synaptic vesicles to the membrane to facilitate
release. Upon fusion of the vesicles, neurotransmitter is released into the
synaptic cleft and binds to postsyanptic receptors. Directly opposite the
presynaptic release machinery is the postsynaptic receptor cluster. This is
indicated in green and is labeled by staining for the essential glutamate
receptor subunit DGluRIII.
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Figure 2.2 Bruchpilot is significantly affected in 141-604
A. Images of 3rd instar larval muscle four NMJs immunolabeled with anti-Brp (red) and
anti-DGluRIII (green).
B. Graph shows quantification of average density of Brp puncta per DGluRIII area
(puncta/microns2). The mutant line 141-604 has a significant decrease in Brp puncta
density (WT- 2.17± 0.35, 141-604- .97±0.05; p=0.007, student’s t-test, two-tailed) Error
bars represent standard error of the mean.
C. Graph shows quantification of the average area of Brp puncta (microns2). 141-604 has
a significant decrease in the area of Brp puncta (WT- 0.41±0.01, 141-604- 0.29±0.009;
p=0.00004, student’s t-test) Error bars represent standard error of the mean.
D. Graph shows quantification of the average intensity of Brp puncta (Arbitrary Units).
141-604 exhibits a significant decrease in intensity of Brp puncta (WT- 59.8±4.6, 141604- 40.8±1.07; p=0.0023, student’s t-test). Error bars represent standard error of the
mean.
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Figure 2.3. Synaptic apposition is defective in 141-604
A. Images of 3rd instar larval muscle 4 NMJs immunolabeled with anti-Brp (red), antiPak (green) and anti-HRP (blue).
B. Graph shows quantification of apposition between Brp puncta and Pak clusters
(fraction of Pak clusters unapposed). There is a significant decrease in synaptic
apposition in 141-604 (WT- 0.98 ± 0.02, 141-604- 0.79±0.02; p= 0.0001, student’s ttest). Error bars represent standard error of the mean.
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Figure 2.4. 141-604 exhibits a defect in synaptic transmission
A&B. Muscle cell (post-synaptic) mEJP recordings from WT (A) and 141-604 (B). An
mEJP is a measure of the response of the postsynaptic cell to spontaneous fusion of a
single synaptic vesicle.
C. Representation of mEJP amplitudes and their relative sizes. There is a shift in the 141604 (orange) mEJPs toward a larger amplitude as compared to the wild-type (blue). An
increase in mEJP amplitude is likely due to a change in the responding muscle cell.
D. Histogram representation of quantal content, a measure of the number of vesicles
released at the synaptic cleft per pre-synaptic stimulation event. The number is
significantly decreased in 141-604. (p=0.0114)
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Figure 2.5 43 is an allele of Bruchpilot (Brp)
Images of third instar larval muscle 4 NMJs immunolabeled with anti-Brp
(red) and anti-DGluRIII (green). A transheterozygote of 43 and Brp exhibits a phenotype very similar to homozygous 43 mutants. These data
indicate that mutant 43 is an allele of Brp.

MA3.5

Figure 2.6 MA3.5 exhibits a severe axon transport defect.
Images of third instar larval nerves immunolabeled with anti-Brp
(red) and anti-HRP (blue). MA3.5 mutants exhibit extensive
large clogs of Brp in their nerves. Brp is virtually undetectable in
wildtype nerves.

Chapter 3

EGFR signaling modulates synaptic connectivity via Gurken

This chapter includes the manuscript:
Naylor SA, DiAntonio A. EGFR signaling modulates synaptic connectivity via Gurken,
Developmental Neurobiology (In Press)
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Abstract
Synaptic target selection is critical for establishing functional neuronal circuits.
The mechanisms regulating target selection remain incompletely understood. We
describe a role for the EGF receptor and its ligand Gurken in target selection of
octopaminergic Type II neurons in the Drosophila neuromuscular system. Mutants in
happyhour, a regulator of EGFR signaling, form ectopic Type II neuromuscular
junctions. These ectopic innervations are due to inappropriate target selection. We
demonstrate that EGFR signaling is necessary and sufficient to inhibit synaptic target
selection by these octopaminergic Type II neurons, and that the EGFR ligand Gurken is
the post-synaptic, muscle-derived repulsive cue. These results identify a new pathway
mediating cell-type and branch-specific synaptic repulsion, a novel role for EGFR
signaling in synaptic target selection, and an unexpected role for Gurken as a musclesecreted repulsive ligand.
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Introduction
Neurons form synapses with appropriate partners to generate complex circuits
during development. These circuits are critical for regulating behavior, homeostasis,
learning and memory. Many different processes guide neurons to their target including
cell migration, axon guidance, and the localization of pre- and post-synaptic components
(Tessier-Lavigne and Goodman 1996). Most neurons recognize their specific targets in
spite of encountering many other cells en route to their destination (Shen and Scheiffele
2010). While there are many examples of finely tuned target selection, the molecular
mechanisms that govern this process remain poorly defined. A better understanding of
these wiring mechanisms is crucial to appreciate circuit assembly and to begin to
understand the consequences of miswiring and its implications in neurological disorders.
The Drosophila larval neuromuscular system is formed by identified pre- and
postsynaptic cells and the wiring pattern is invariant, making it a powerful system to
study synaptic connectivity. The primary innervations are glutamatergic, are responsible
for fast synaptic transmission, and are subdivided into Type Ib and Is based on the
innervation pattern and bouton morphology (J. Johansen et al. 1989). The second major
class of neuromuscular junctions (NMJs) are termed Type II, and are octopaminergic and
neuromodulatory (Monastirioti et al. 1995). Type II NMJs are present on fewer muscles
of the larva and have a distinctive morphology. Neurons forming Type Is NMJs innervate
multiple muscle targets in a given hemisegment (Landgraf et al. 1997) whereas Type II
neurons innervate a different complement of muscle targets in the same region
(Monastirioti et al. 1995). These two types of neurons encounter the same muscle field
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and yet make divergent target selection choices, making this an interesting system in
which to study synaptic target selection.
One advantage of the Drosophila system is the ability to unravel mechanisms of
target selection genetically (Collins and DiAntonio 2007). Many of the most striking
targeting phenotypes result from gain-of-function rather than loss-of-function studies
(Ghose and Van Vactor 2002). For example, overexpression of muscle-derived Fasciclin
II (FasII) potently promotes the formation of ectopic synapses that are functional and
stable (Davis, Schuster, and Goodman 1997). Loss-of-function studies may find less
dramatic phenotypes because targeting decisions are complex and involve the integration
of a number of positive and negative cues (Winberg, Mitchell, and Goodman 1998).
Indeed, when their normal muscle targets are ablated, motoneurons retain the ability to
synapse on alternate muscles (Cash, Chiba, and Keshishian 1992). This suggests that the
target selection of neurons is a malleable process that requires multiple simultaneous
cues. In addition to molecular cues, decreases in neuronal activity via mutations in
sodium channel subunits also lead to the formation and stabilization of ectopic synapses
(Jarecki and Keshishian 1995). Recent studies have highlighted the important role of
electrical activity and semaphorin signaling in shaping synaptic connectivity in this
system (Carrillo et al. 2010; Koon et al. 2011). Despite this progress, it is still not clear
how Type II octopaminergic neurons distinguish between appropriate and inappropriate
targets, and more generally, how neurons navigate to their appropriate targets to form
synaptic connections.
To address this question, we undertook a genetic screen to identify mutants with
defects in synaptic targeting. From this screen we identified a role for EGFR signaling in
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Type II neuron target selection. We find that EGFR signaling inhibits synaptic target
selection in a cell-type and branch-specific manner. The inhibitory cue is provided by a
muscle-derived EGFR ligand, Gurken. This is a novel function for Gurken, which was
previously suggested to function exclusively in the developing oocyte (Nilson and
Schüpbach 1999). This work defines EGFR and Gurken as an important receptor/ligand
pair contributing to the array of signals shaping the development of neural circuits.
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METHODS

Fly Stocks
Flies were maintained at 25°C on standard fly food. Wild type (WT) flies were
Canton S (CS) unless specified otherwise. The following flies were obtained from the
Bloomington Stock Center: P{SUPor-P}hppyKG05537, Df(2R)Exel6069, Tdc2-Gal4 (Koon
et al. 2011), UAS-CD8-GFP (T. Lee and Luo 1999), rl1 (Biggs et al. 1994), UAS-DCR2
(Y. S. Lee et al. 2004), G7-Gal4, M12-Gal4, UAS-EGFR (2nd chromosome) (Carmena et
al. 1998), gurken2B (Neuman-Silberberg and Schüpbach 1993), UAS-EGFRDN, and UASRhomboid (Guichard et al. 1999).
UAS-hppy was a gift from Ulrike Heberlein (UCSF, CA). UAS-Gurken RNAi (36251 &
101701) was from the Vienna Drosophila Genome Resource Center (Vienna, Austria).
UAS-Gurken was a gift of Bruce Edgar (Jiang and Edgar 2009).
Immunohistochemistry
Third-instar larvae were dissected in PBS and fixed in either Bouin’s fixative for
5 min. or 4% paraformaldehyde for 30 min on ice. Larvae were washed with PBS
containing 0.1% Triton-X-100 (PBT) and blocked in 1% NGS in PBT for 30 min,
followed by overnight incubation in primary antibodies in 1% NGS in PBT, three washes
in PBT, incubation in secondary antibodies in 1% NGS in PBT for 45 min, three final
washes in PBT, and equilibration in 70% glycerol in PBS. Samples were mounted in
Vectashield (Vector, Burlingame,CA). The following primary antibodies were used:
rabbit α-DGluRIII (Marrus et al. 2004) 1:2500 in Bouin’s, mouse α-FasII (clone 1D4)
1:5 in PFA, 1:100 in Bouin’s, rabbit α-Vmat (Greer et al. 2005) 1:200 in PFA, mouse α-
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Brp (Wagh et al. 2006)1:200 in Bouin’s, mouse α-Futsch 1:100 in Bouin’s, rabbit αSynaptotagmin1 (Mackler et al. 2002) 1:2500 in Bouin’s, rat α-mCD8a (Invitrogen)
1:100 in Bouin’s, rabbit α-TBH (Koon et al. 2011) 1:400 in Bouin’s, rabbit anti-GFP
conjugated to Alexa Fluor-488, 1:200 (Invitrogen). Goat Cy3-, Alexa-633 and FITC
conjugated secondary antibodies against mouse and rabbit IgG were used at 1:1000 and
were obtained from Jackson ImmunoResearch. Chicken Cy3 conjugated secondary
antibody against rat IgG was used at 1:200. Antibodies obtained from the Developmental
Studies Hybridoma Bank were developed under the auspices of the National Institute of
Child Health and Human Development and maintained by the Department of Biological
Sciences of the University of Iowa, Iowa City, IA.
Imaging and Analysis
Samples were imaged with a Nikon D-Eclipse C1 confocal microscope using 60X
oil objective. Shown images are z projections of confocal stacks acquired from serial
laser scanning except for the Tdc2-GFP cell bodies which are presented as single
confocal sections. Quantification was performed to determine presence or absence of
FasII and Vmat positive projections on muscles 6,7,12, 13, and 4. These muscles were
examined in segments A3-A5. Values were analyzed for significance using the Fisher’s
exact test and two-tailed P value tests. Type I boutons were counted on muscles 6 and 7
of segment A3 and analyzed with a two-sample t-test. Type Is bouton presence was
examined on muscles 12,and 13 in segments A3-A5 and analyzed with Fisher’s exact test
and two tailed P value tests. Length of Type II synapses in segments A3-A5, was
quantified using ImageJ and significance was calculated with a two-sample t-test.
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RESULTS

To identify pathways and mechanisms that govern synaptic growth and
development, we performed a genetic screen of several collections of Drosophila mutants
including p-element insertions from the BDGP project (Bellen et al. 2004). We dissected
third-instar larvae from each line and stained with a marker of the presynaptic active zone
Bruchpilot (Brp) (Wagh et al. 2006) and the essential glutamate receptor subunit
DGluRIII (Marrus and DiAntonio 2004). We identified lines with defects in synaptic
development including synaptic targeting defects, active zone defects, and NMJ
morphology defects. From this screen we identified an allele of happyhour (hppy),
P{SUPor-P}KG05537, which has a defect in synaptic targeting of the octopaminergic
motoneurons that form Type II NMJs.
These octopaminergic motoneurons face an interesting problem: how do they
choose their multiple synaptic targets and bypass other potentially suitable locations to
form a synapse? The normal innervation pattern of the Type II motoneuron MNSNb/d-II
and the Type Is motoneuron MNSNb/d-Is is shown in Fig 3.1A. Motoneuron MNSNb/dIs forms three branches that innervate the cleft between muscles 6 and 7, muscle 13 and
muscle 12 respectively. In contrast, the axon from motoneuron MNSNb/d-II extends
under muscles 6 and 7 without forming a synapse, and then branches twice to form NMJs
onto muscles 13 and 12. In hppy mutants, however, ectopic Type II NMJs are more likely
to form on muscles 6 and 7 than in wild type (Fig 3.1B, 3.1C). We conclude that these
ectopic NMJs are Type II endings because, like wild type Type II NMJs, they 1) are long
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and thin with very small synaptic boutons and 2) express the vesicular monoamine
transporter (VMAT)(Greer et al. 2005), which exclusively labels octopaminergic Type II
NMJs in the periphery. In the higher magnification panels, colocalization between FasII
and VMAT occurs in wild type Type II NMJs as well as the ectopic Type II NMJs in
hppy mutants.
It is possible that these ectopic Type II NMJs may represent immature or
defective Type II synapses. To investigate this possibility we labeled Type II synapses in
wildtype and hppy mutants by expressing UAS-CD8-GFP, a membrane targeted GFP,
with Tdc2-Gal4, which in the periphery expresses exclusively in octopaminergic neurons
(Cole et al. 2005). We find that the ectopic Type II synapses in hppy exhibit expression of
tyrosine beta-hydroxylase (TBH) (Fig 3.1E). TBH is necessary to synthesize octopamine
and is necessary for mature Type II NMJ function. To determine if the ectopic Type II
NMJs contain machinery for synaptic release, we examined the localization of the active
zone component Bruchpilot (Brp). Brp is present in the ectopic Type II NMJs in hppy
mutants (Fig 3.1F). In addition, the MAP1B-related protein Futsch and the synaptic
vesicle protein Synaptotagmin-1 are also present in the ectopic Type II NMJs (Fig 3.1G,
H). Together, these data indicate that the ectopic Type II endings on muscles 6 and 7 in
hppy mutants have the anatomical hallmarks (Koon et al. 2011) of mature Type II NMJs.
The establishment of Type I innervation occurs before Type II innervation and is
critical to guide the Type II neurons to their appropriate locations (Halpern et al. 1991).
To test the possibility that the ectopic Type II innervation is due to a primary defect in
Type I innervation, we examined Type Ib and Is innervations on muscles 6, 7, 12, and 13.
We find no difference in the number of Type I boutons on muscles 6 and 7 in the hppy
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mutant (WT= 79.1± 3.0; hppy= 87.5±6.8 p=0.29) or detectable differences in their
morphology. Type Is boutons are present on muscles 12 and 13 both in wild type and
hppy mutants (p=1 for muscles 6/7,12 and13). Hence, Type I innervation appears to be
unaffected in hppy mutants and so is unlikely to contribute to the formation of ectopic
Type II NMJs.
To assess whether this synaptic phenotype is due to loss of hppy, we generated
transheterozygotes for hppyKG05537 and a deficiency chromosome, Df(2R)Exel6069, that
deletes hppy and adjacent genes. We find no significant difference in the presence of
ectopic Type II synapses between hppy and hppy/df (p> 0.05) (Fig 3.1C). Hence, this
phenotype is not due to a second site mutation on the hppyKG05537 chromosome. In
addition, since the hppyKG05537 phenotype was not exacerbated in combination with a
definitive null allele, the hppyKG05537 allele is behaving as a genetic null or a very strong
hypomorph. This phenotype is not restricted to muscles 6 and 7—hppy mutants also have
a significant increase in the likelihood of ectopic Type II innervation on muscle 4 (WT
18% ± 0.6% n=60; hppy 50%± 0.8% n=60 p= 0.0005). Type II synapses are found on
muscles 12 and 13 in wild-type animals (Fig 3.1C). Potentially, the ectopic Type II
synapses on muscles 6 and 7 in hppy mutants are being formed at the expense of normal
Type II innervation onto muscles 12 and 13. In this scenario, these Type II synapses
would be significantly smaller or absent altogether. To investigate this possibility, we
measured total Type II synaptic span on muscles 12 and 13 and found that Type II
synapses are unaffected in hppy mutants (M12; WT 296 ± 25 µm, hppy 301 ± 46 µm
p=.92, M13; WT 371 ± 45 µm, hppy 308 ± 44 µm p=.33 n=10) (Fig 3.1D). In addition,
we observed no missing type II NMJs on these muscles (n = 20). This demonstrates that
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the Type II synapses at muscles 6 and 7 in hppy mutants are not misplaced synapses that
should be located on muscles 12 and 13, but are ectopic synapses formed in addition to
the normal complement of Type II synapses.
To investigate the cellular basis for these ectopic synapses, we analyzed the cell
number and projection pattern of octopaminergic motoneurons. In wild-type larvae, there
are clusters of three octopaminergic (Type II) neurons in the ventral nerve cord
corresponding to each segment of the animal. These neurons each have one process that
bifurcates within the ventral nerve cord forming bilateral projections to each
hemisegment. These projections then branch in the periphery and form Type II NMJs at
appropriate locations within the hemisegment. In light of this anatomy, there are three
potential explanations as to the source of the ectopic synapses: 1) hppy mutants have an
increase in octopaminergic cell number 2) existing octopaminergic neurons form
additional primary branches within the nerve cord or 3) the existing octopaminergic
neuronal projections are forming ectopic branches in the periphery. To distinguish among
these possibilities, we counted octopaminergic neuron cell bodies and their primary
projections in wild-type and hppy mutant larvae. In order to count these neurons, we
expressed UAS-CD8-GFP, a membrane targeted GFP, with Tdc2-Gal4. In wild-type
larvae there are clusters of three octopaminergic neurons in each segment of the animal
(Fig 3.2A). In hppy larvae there are also three octopaminergic neurons per segment (WT3; hppy-3; n=10; p=1). To assess the number of primary projections formed by these
neurons, we counted the number of labeled axons innervating each hemisegment and
determined that the number of projections was the same (WT-3; hppy-3; n=10; p=1) in
hppy and wild-type (Fig 3.2B). Following these GFP positive projections to their targets,
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we confirmed that the ectopic synapses in hppy mutants form from the extensions of the
TDC2 positive neurons (Fig 3.2C). These ectopic synapses in hppy mutants can originate
from extensions of MNSNb/d-II, the Type II neuron that normally innervates muscles 12
and 13, or occasionally from MNISN-II whose projection runs in the intersegmental
nerve and that normally innervates more lateral targets. Hence, the wiring defects in the
hppy mutant are due to ectopic branching of octopaminergic projections within their
muscle target field.
To test whether this phenotype is due to loss of happyhour in octopaminergic
neurons, we expressed UAS-hppy with Tdc2-Gal4 in the happyhour background in an
effort to rescue the ectopic synapse phenotype. Expression of happyhour in
octopaminergic neurons reduces the frequency of ectopic synapses in hppy mutants (Fig
3.2D&E) (p < .05). While our rescue is statistically significant, it does not fully
recapitulate wild-type innervation, potentially due to the strength or timing of expression
from TDC2-gal4. Overexpression of hppy in a wild-type background does not show a
significant change in either Type II NMJ structure or target selection (data not shown).
hppy regulates EGF receptor (EGFR) signaling that can modulate downstream
activation of ERK, known in Drosophila as rolled (rl) (Corl et al. 2009). We investigated
whether or not this same signaling pathway is responsible for the ectopic synapse
phenotype. To test whether overactivation of rolled downstream of happyhour is
responsible for the ectopic Type II synapses, we made a double mutant of happyhour and
a hypomorphic allele of rolled (rl1) (Biggs et al. 1994). We find that homozygous
rl1mutants do not have any changes in Type II innervation in an otherwise wild type
background (Fig 3.3A). However, the rl1 mutant potently suppresses the ectopic Type II
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synapses in hppy mutants (Fig 3.3A). This suppression is essentially complete (Fig 3.3B)
(p < .005).
Suppression with rl1 suggests that the phenotype is due to an overactivation of the
EGFR pathway, however, such overactivation often leads to strong negative feedback.
Such feedback ensures that strong activation of the pathway is quickly and effectively
turned off (Avraham and Yarden 2011). Indeed, baseline levels of p-ERK are
significantly decreased in hppy mutants, indicating that the pathway is turned down (Corl
et al. 2009). Hence, while the findings with hppy and rl implicate EGFR signaling in the
restraint of ectopic synapse formation, they are unable to distinguish the directionality of
the signal. To investigate the role of EGFR directly, we manipulated the receptor in
octopaminergic neurons. We expressed a dominant negative EGFR construct, UASEGFR-DN (M Freeman 1996), with the Tdc2-Gal4 driver (Fig4A). This inhibition of
EGFR function in octopaminergic neurons results in a significant increase in the number
of ectopic Type II NMJs on muscles 6 and 7 (Fig 3.4B) (p< .05). This suggests that
EGFR acts within octopaminergic neurons to inhibit inappropriate innervation. If so, then
overexpression of EGFR in octopaminergic neurons may overactivate this repulsive
signal and may lead to the loss of Type II innervation onto muscles 12 or 13, the normal
synaptic partners of these neurons. To investigate this hypothesis, we expressed wild-type
EGFR (UAS-EGFR) with the Tdc2-Gal4 driver (Fig 3.4C). This led to a significant
decrease in the proportion of muscle 12 cells with Type II NMJs (Fig 3.4D) (p< .005).
Taken together, these loss- and gain-of-function studies demonstrate that EGFR signaling
is necessary and sufficient to inhibit the capacity of octopaminergic motoneurons to form
NMJs with targets.
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Since EGFR signaling mediates a branch-specific repulsive signal in
motoneurons, a muscle-derived ligand is likely the inhibitory cue. There are several
known ligands of the EGFR, including Vein, Spitz, Keren and Gurken (Schnepp et al.
1996) (Rutledge et al. 1992) (Reich and Shilo 2002) (Neuman-Silberberg and Schüpbach
1993). To test whether any of these is the repulsive cue, we knocked down expression of
each ligand via RNAi expressed under the control of a muscle specific driver, G7-gal4
(Y. Q. Zhang et al. 2001). Knockdown of Vein, Spitz and Keren has no synaptic
phenotype. In contrast, knockdown of Gurken recapitulates the dominant negative EGFR
phenotype (Fig 3.5A). Expression of an RNAi targeting Gurken (VDRC36251) leads to a
significant increase in ectopic Type II innervations on muscles 6 and 7 (Fig 3.5A,B) (p<
.05). Similar results were obtained with a second Gurken RNAi (VDRC101701) (p<.05)
that shares no common sequence with VDRC36251 as well as the homozygous gurken2B
mutant (Neuman-Silberberg and Schüpbach 1993), which has ~25% ectopic Type II
NMJs at muscles 6 and 7 (p<.05) (Fig 3.5A,B).
As a second test of this model, we asked whether overexpression of Gurken is
sufficient to inhibit octopaminergic NMJ formation at the normal target. We expressed
UAS-Gurken and its processing enzyme UAS-Rhomboid with M12-Gal4, which expresses
in muscle 12, a normal synaptic target for MNSNb/d-II (Fig 3.6A). Overexpression of
Gurken and Rhomboid in muscle 12 is sufficient to inhibit the formation of Type II NMJs
at their normal targets (Fig 3.6B). These loss- and gain-of-function studies strongly
support the model that Gurken is an inhibitory cue for octopaminergic synaptogenesis. To
shape target selection, however, the model predicts that Gurken expression should be
localized to muscles that do not receive octopaminergic input, such as 6 and 7.
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Unfortunately, we are unable to confirm this aspect of the model via in situ or antibody
staining, as we have been unable to detect endogenous gurken transcript or protein in any
muscles. Although it cannot speak to muscle specific expression, the modEncode RNAseq data does demonstrate that Gurken is enriched in body wall muscle (Chintapalli,
Wang, and Dow 2007), supporting our genetic findings that Gurken functions outside of
the developing oocyte.
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DISCUSSION

Synaptic target selection is a critical step in establishing functional neural circuits.
The molecular mechanisms governing this selection have not yet been fully explored. We
have taken our observation that hppy mutants have an increased frequency of ectopic
octopaminergic Type II NMJs and identified a pathway critical for synaptic target
recognition in these neurons. We find that the EGFR signaling pathway is required to
prevent the development of inappropriate synaptic contacts. This inhibitory signal is
mediated by muscle-derived EGFR ligand, Gurken, working through the EGF receptor in
type II motoneurons. This mechanism sculpts the neuronal wiring pattern in a cell-type
and branch-specific manner.

EGF as a guidance cue
There are many signaling pathways that influence the innervation pattern of
Drosophila motor neurons. Our findings identify a novel role for EGFR signaling in
mediating a repulsive guidance cue to Type II neurons. EGF has previously been
demonstrated to regulate axon growth and guidance. For example, EGF positively
regulates Sema-3a levels in the cornea (Ko et al. 2008) and interacts with NCAM-180 to
promote neuritogenic activity (Povlsen, Berezin, and Bock 2008). However, to our
knowledge our data is the first to demonstrate that an EGF receptor and ligand provide a
synaptic targeting signal.
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We find ectopic Type II NMJs in hppy mutants, as well as when we express a
dominant negative EGFR in Type II neurons or knock down its ligand Gurken in the
muscle targets. This presents an apparent contradiction. Hppy is described as a negative
regulator of EGFR (Corl et al. 2009), and its phenotype in this system is suppressed by a
hypomorphic mutation in rolled (ERK), consistent with Hppy functioning as a negative
regulator of EGFR signaling. Why then does loss of hppy have the same phenotype as
inhibition of the receptor or ligand? We posit that the well-described strong negative
feedback (Avraham and Yarden 2011) induced by EGFR signaling may be the
explanation. We propose a model in which activation of the EGFR pathway mediates a
signal that inhibits the formation or stabilization of Type II NMJs. In hppy mutants,
however, loss of negative regulation would allow for excess activation of the EGFR that
would induce a quick, strong and long-lasting negative feedback activity early in
development, essentially turning off EGFR signaling in cells expressing happyhour. The
result would be loss of the synaptic inhibitory signal mediated by EGFR at the stage
when these Type II neurons are extending to their targets and the promotion of ectopic
synapse formation. We appreciate that this model is speculative, and that an alternative is
that hppy and rolled are regulating a pathway that is distinct from the EGFR/gurken
pathway.

EGFR and synapse formation
By what mechanism does EGFR signaling affect synapse formation in Type II
neurons? Presumably, there is a molecular program downstream of EGFR activation that
modifies the Type II neuron such that it does not form and/or maintain an NMJ with an
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inappropriate target. These changes could occur at the level of the cell body or locally
within individual branches. It is unlikely that cell body changes are central to the
phenotype because such neuron-wide mechanisms could not easily be translated into
branch-specific behavior. In contrast, local effects of EGFR signaling within neurites
could explain such specificity. We do not know the cell biological mechanism mediating
the branch-specific inhibition. Possibilities include alterations in the local translation or
membrane insertion of synaptogenic molecules, local modulation of cytoskeletal
dynamics, or failure to properly prune Type II connections.
Not only is the EGFR mediating a branch-specific effect, but it is also cell-type
specific. As described above, the Type II motoneuron MNSNb/d-II and the Type Is
motoneuron MNSNb/d-Is travel together and presumably encounter the same cues across
the hemisegment, however they generate different innervation patterns. This implies that
these two types of neurons have developed cell-type specific repertoires of receptors or
signaling pathways that shape their target choices.
While our data indicate a role for EGFR signaling in Type II synaptic target
selection it is also likely that Type II target selection has multiple components. Our
phenotypes occur at a relatively low penetrance, so it is likely that complementary and
combinatorial guidance cues function with the EGFR pathway to shape target selection of
Type II neurons.

A novel role for Gurken
Gurken has been studied exclusively in the developing oocyte (Schüpbach 1987)
(Neuman-Silberberg and Schüpbach 1993) (González-Reyes, Elliott, and St Johnston
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1995) and, to our knowledge, has no known roles in other tissues. Hence, it is surprising
that Gurken conveys the repulsive signal from muscle to the octopaminergic Type II
neurons. In support of a function in muscle, the modEncode RNA-seq project has found
that Gurken transcript is enriched 3.5 fold in larval body wall muscles (Chintapalli,
Wang, and Dow 2007). While Gurken may be secreted from all muscles, we prefer a
model in which localized expression in a muscle subset shapes the branching pattern of
the innervating motoneuron. In this model, Gurken released from muscles 6 and 7, as
well as other targets that should not be innervated, would locally inhibit synaptogenesis,
blocking the formation of ectopic connections while allowing for the normal innervation
at muscles 12 and 13. This model is consistent with our findings that knockdown of
Gurken in muscle results in ectopic NMJs while localized overexpression in the normal
target cell inhibits formation of appropriate NMJs. While these functional data are strong,
our model must remain speculative because we have been unable to determine the
localization of Gurken using currently available reagents. Future studies will investigate
how this Gurken/EGFR pathway is integrated with the recently defined semaphorin- and
activity-dependent mechanisms that also play an important role in shaping synaptic target
selection in these neurons (Carrillo et al. 2010).
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Figure 3.1. hppy mutants have ectopic Type II synapses
A. Schematic detailing the innervation pattern of a wild-type larval ventral muscles. Red
represents Type I glutamatergic innervations. Green represents Type II octopaminergic
innervations. Muscles are identified by number. L corresponds to lateral and M
corresponds to medial.
B. Images of 3rd instar larval muscles 6 and 7 with neurons immunolabeled with antiFasII (red) and anti-Vmat (green). Arrowheads indicate ectopic Type II innervations
positive for Vmat. Scale bars represent 50 µm.
C. Histogram shows quantification of the presence of Type II innervation on muscles 6
and 7 (percent of muscles innervated by Type II synapses). hppy larvae have a significant
increase in the presence of Type II innervation on muscles 6 and 7 (WT 1.8% ± .4%
n=54; hppy 16% ± 1.4% n=54; WT:hppy p<.05 Fisher’s exact test). hppy/def flies also
have a significant increase in the presence of Type II innervation on muscles 6 and 7
(hppy/def 13% ± .8%; n=92; WT:hppy/def p< .05 Fisher’s exact test). Error bars represent
95% confidence interval.
D. Images of muscles 12 and 13, Arrowheads indicate normal Type II innervations that
are unaffected in hppy mutants. Scale bars represent 50 µm.
E-H. Images of wild-type (WT) Type II synapses on muscle 12 and ectopic Type II
synapses in hppy mutants on muscles 6 and 7. Synapses are labeled with markers of
mature Type II innervation. Scale bars represent 1µm.
E. Type II NMJs immunolabeled with anti-mCD8 (Tdc2-GFP)(green), anti-TBH (blue)
and anti-FasII (red).
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F. Type II NMJs immunolabeled with anti-mCD8 (Tdc2-GFP)(green), anti-TBH (blue)
and anti-Brp (red).
G. Type II NMJs immunolabeled with anti-mCD8 (Tdc2-GFP)(green), anti-TBH (blue)
and anti-Futsch (red).
H. Type II NMJs immunolabeled with anti-mCD8 (Tdc2-GFP)(green), and anti-Syt1
(red).
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Figure 3.2. Ectopic synapses result from a targeting defect of the existing Type II
neurons
A. Single confocal sections of Type II neuronal cell bodies expressing UAS-CD8-GFP
under Tdc2-Gal4 control. hppy mutants do not exhibit an increased number of Type II
neurons. (WT-3; hppy-3; n=10; p=1) Scale bars represent 5 µm.
B. Images of projections expressing UAS-CD8-GFP under Tdc2-Gal4 control in Type II
neurons. hppy mutants do not exhibit an increased number of projections from Type II
neurons. (WT-3; hppy-3; n=10; p=1) Scale bar represents 1µm.
C. Images of projections expressing UAS-CD8-GFP under Tdc2-Gal4 control. The Tdc2GFP projections form the ectopic Type II synapses in hppy mutants. FasII (red) labels
neuronal membranes. Scale bar represents 5 µm.
D. Images of larval muscles 6 and 7, neurons immunolabeled with FasII (red) and Vmat
(green). Ectopic Type II innervations found in hppy mutants are rescued by expression of
UAS-hppy with Tdc2-Gal4 (Type II neuron specific). Scale bar represents 10 µm.
E. Quantification of the presence of Type II innervation on muscles 6 and 7. Type II
neuron specific rescue of hppy mutants significantly suppressed ectopic Type II
innervations on muscles 6 and 7. Tdc2-hppy 7.1% ± 1.2% n=42; hppy 22% ± .6% n=150;
hppy; Tdc2-hppy 13% ± .4% n=150) ( hppy : hppy;Tdc2-hppy p < .05 Fisher’s exact test).
Error bars represent 95% confidence interval.
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B) Quantification of the presence of Type II innervations on
muscles 6 and 7. A double mutant of hppy and rolled significantly suppresses the hppy phenotype (WT 3.3% ± .59%
n=60; rl/rl 1.7% ± .4% n=59; hppy 18.3% ± 1.2% n=60;
hppy,rl/hppy,rl 1.6% ± .4%) (hppy: hppy,rl/hppy,rl p < .005
Fisher’s exact test). Error bars represent 95% confidence
interval.
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Figure 3.4. EGFR is necessary and sufficient to inhibit Type II innervation
A. Images of muscles 6 and 7 immunolabeled with anti-Vmat (green) and anti-FasII
(red). Loss of EGFR signaling in Type II neurons results in ectopic Type II innervation
on muscles 6 and 7.
B. Graph shows quantification of the presence of Type II innervation on muscles 6 and 7.
Loss of EGFR signaling results in a significant increase in Type II innervation on
muscles 6 and 7 (Tdc2/+ 3.4% ± .4% n=100; UAS-EGFR-DN 6.1% ± .4% n=100; Tdc2UAS-EGFR-DN 14.9% ± .8% n=100) (Tdc2/+ : Tdc2-EGFR-DN p< .05; UAS-EGFRDN:Tdc2-UAS-EGFR-DN p< .05) Fisher’s exact test). Error bars represent 95%
confidence interval.
C. Images of muscles 12 and 13 immunolabeled with anti-Vmat (green) and anti-FasII
(red) M12 and M13 notations indicate location of muscles. Arrowhead indicates normal
Type II innervation found on Muscle 12. Arrow indicates absence of Type II innervation
on Muscle 12 when UAS-EGFR is overexpressed with Tdc2-Gal4.
D. Graph shows quantification of the absence of Type II innervations on Muscle 12.
Overexpression of wild-type EGFR with a Type II neuron specific driver results in a
significant number of muscles 12 that are not innervated by Type II synapses (Tdc2/+ 2%
± .6% n=50; UAS-EGFR/+ 0% n=50; Tdc2-UAS-EGFR 21% ± 1.6% n=50)
(Tdc2/+:Tdc2-UAS-EGFR p< .005; UAS-EGFR/+:Tdc2-UAS-EGFR p= .0005 Fisher’s
exact test). Error bars represent 95% confidence interval.
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Figure 3.5. Gurken ligand is necessary to
mediate a repulsive signal through EGFR
A. Images of muscles 6 and 7 immunolabeled
with anti-Vmat (green) and anti-FasII (red).
Knockdown of Gurken in the muscle results in
ectopic Type II synapses on muscles 6 and 7.
Gurken2B mutants also exhibit ectopic Type II
synapses on muscles 6 and 7. Scale bars represent 10 µm.
B. Graph shows quantification of the presence of
Type II innervation on muscles 6 and 7. Knockdown of Gurken in the muscle results in a significant increase in Type II innervation on muscles 6
and 7 (UAS-Dcr2;G7gal4/+ 0% n=36; UAS-Grk
RNAi 0% n=36; UAS-Dcr2;G7gal4/UAS-Grk RNAi
16% ± 2% n=36; Gurken2B 25.9% ± 1.2% n= 77)
(UAS-Dcr2;G7gal4/+ : UAS-Dcr2;G7gal4/UASGrk RNAi p< .05 Fisher’s exact test) (UASDcr2;G7gal4/+ : Gurken2B p<.0005 Fisher’s
exact test). Error bars represent 95% confidence
interval.
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Figure 3.6. Gurken ligand is sufficient to inhibit
Type II innervation through EGFR
A. Images of muscles 12 and 13 immunolabeled
with anti-Vmat (green) and anti-FasII (red). Expression of UAS-Gurken and UAS-Rhomboid with the
muscle 12 specific driver M12-Gal4 results in a loss
of Type II synapses on muscles 12 and 13. Scale
bars represent 50 µm.
B. Graph shows quantification of the loss of Type II
innervation on muscles 12 and 13. (M12/+ 2.8%±
.2% n=70; UAS-Gurken, UAS-Rhomboid/+ 1.4% ±
.2% n= 70; M12/UAS-Gurken, UAS-Rhomboid
13.6% ± .5% n=66 ) (M12/+:M12/UAS-Gurken,
UAS-Rhomboid p= 1; UAS-Gurken, UASRhomboid/+: M12/UAS-Gurken, UAS-Rhomboid
p<.05 Fisher’s Exact Test). Error bars represent 95%
confidence interval.
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Discussion
In this dissertation, I have performed a forward genetic screen of multiple
collections of mutants in order to uncover new genes involved in synaptic development. I
have isolated many mutants with a variety of phenotypes ranging from general growth
defects, to specific defects in the components of the presynaptic release machinery. I
have characterized three of these mutants in more detail with the in depth characterization
of happyhour leading to the publication in Chapter 3. Here I will discuss the results and
implications of my thesis work more in depth.

Forward genetic screening for defects in synaptic development
Forward genetic screening is an unbiased approach to uncovering novel regulators
of synaptic development. By screening three divergent collections of mutants or RNAi
lines, I have been able to generate a diverse list of mutants and RNAi lines which affect
synaptic development. While time constraints have precluded study of all of these lines,
many of these genes have since been published by other groups and many remain to be
studied in the lab. For example, I found the gene srpk79D to have a defect in axonal
transport with large aggregates of Brp clogging the axons. It has since been shown to be a
kinase that regulates the assembly of Brp molecules and normally acts to prevent their
assembly until they reach the NMJ (Nieratschker et al. 2009). While my screens did
identify several genes that already have known roles in synaptic development, the
identification of several novel genes demonstrates the utility of this sort of approach.
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Bruchpilot mutant phenotypic variance
The allele of Bruchpilot that we identified as a second site mutation in a piggyBac insertional mutant is a great example both of the constantly evolving genomes of
flies in the lab and the variability of phenotype for any given gene. The published
phenotypes for Bruchpilot mutants include: decrease in immunoreactivity of nc82
antibody, decreased number of T bar structures at active zones, reduction in evoked
response, reduced quantal content, and increased miniature epsp amplitude, and
mislocalization of presynaptic calcium channels (Wagh et al. 2006; Robert J Kittel,
Wichmann, et al. 2006). The allele that I isolated appeared to be a very weak allele as
there was a slight decrease in the number of Brp puncta and the intensity of those puncta.
We also observed an increase in miniature epsp amplitude and the concomitant decrease
in quantal content. Our allele however, also exhibited some post-synaptic defects in that
the receptor clustering was diffuse. These slight variances and relative weakness of our
allele along with the piggyBac insertion originally led us to believe our allele was that of
another gene. It is interesting to note that our allele did have a slight variance in the
phenotype from other published alleles. It is possible the mutation in our allele affected
only a small domain of bruchpilot. It is also possible that the variation we saw in the
post-synaptic receptors was merely a genetic background effect and was not influenced
by bruchpilot at all.
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Beta-Spectrin in disease
Spinocerebellar ataxia type 5 (SCA5) is an autosomal dominant
neurodegenerative disorder caused by mutations in Beta-Spectrin. When SCA5 mutation
containing transgenes are expressed in Drosophila, larvae exhibit posterior paralysis,
reduced synaptic terminal growth and axonal transport defects (Lorenzo et al. 2010). We
identified an allele of Beta-Spectrin, MA3.5, in our forward genetic screen. MA3.5 has a
significant axonal transport defect but does not exhibit any of the other known
phenotypes of Beta-Spectrin mutants such as posterior paralysis or smaller synaptic
terminals. It is interesting that our allele most closely resembles the overexpression of
spino-cerebellar ataxia (SCA5) causing mutations. It is possible that the MA3.5 allele
has increased expression of Beta-Spectrin and is causing the axonal transport defects. It
is also possible that overexpression is occurring and there is also a mutation affecting the
function of Beta-Spectrin. MA3.5 represents a possible model for SCA5 without
introducing transgenic overexpression of disease constructs.

Happyhour’s influence at the NMJ
Happyhour is a Ste20 kinase about which relatively little is known. It is known to
function in neurons to modulate responsiveness to alcohol (Corl et al. 2009). My work
corroborates these data in that hppy modulates EGFR signaling in Type II neurons
specifically. It is possible that happyhour’s primary role in neurons is to modulate EGFR
signaling for a particular purpose. It is not known whether its primary function is to
modulate synaptic target selection, modulate alcohol sensitivity or another as yet
undiscovered function. It is also possible that hppy is meant to modulate all processes
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requiring EGFR in the neuron and this explains the pleiotropy we find in hppy mutants. It
would be interesting if this is the case because it is yet another mechanism to refine
EGFR signaling in addition to negative and positive feedback loops. It also helps to
prevent any “slop” in the system from causing any changes that affect cell fate or
specification. Future work may be able to delineate whether happyhour is a general
modulator or a modulator of specific aspects of EGFR signaling.

EGFR as a guidance pathway
There are many known pathways that influence axonal and synaptic guidance. My
work is the first that indicates a role for EGFR in synaptic target selection. It is not
surprising that there are targeting pathways that have yet to be identified. Providing
guidance and specificity to so many neurons with so many targets should require a
complex combinatorial code of guidance cues in order to generate such specificity. EGFR
signaling is well suited to this sort of task due to its refined response capabilities to
activate a downstream signaling pathway in a single cell without influencing nearby
neighbor cells. The relatively low penetrance of the phenotype I observe in Type II target
selection suggests that there are other pathways also influencing this particular target
selection event. It is also possible that EGFR is involved other target selection events
other than those I’ve described in the Type II neurons.

Gurken outside the oocyte
It was very surprising to find that Gurken is the EGFR ligand responsible for
mediating target selection of Type II neurons. Most of the literature strongly asserts that
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Gurken plays a role only in the developing oocyte. It is possible that this body of research
has been focused so narrowly that a role in later development could have been missed
entirely. I have been unable to demonstrate Gurken expression in the larval muscles
myself, which suggests that observing this expression at the exact time when it must be
occurring is not trivial. It is possible that Gurken is secreted from a select group of
muscles for a very short time window as all of the axon extension and target selection
happens within six hours. To generate synaptic specificity many pathways must be
employed, in this context it is less surprising that an alternative ligand that has already
performed its primary patterning functions is employed.

Future Directions
There are a number of questions as yet unanswered about the role of EGFR
signaling in target selection. It will be critical to determine if the EGFR negative
feedback mechanism is activated in hppy mutants. It will also be interesting to determine
if activity of the Type II neurons can modulate the ectopic synapse phenotype. Activity
has been shown to modulate synaptic outgrowth and maintenance (Koon et al. 2011;
Carrillo et al. 2010). More broadly, the complete mechanism contributing to synaptic
development is still a mystery. It is possible that some of the other mutants I have found
will contribute to delineating other molecules and pathways critical for synaptic
development.
Conclusions
In conclusion, synaptic development is a complex and critical process necessary
for establishing the proper connectivity and function of neural circuits. These neural
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circuits are the foundation of the nervous system and the basis of learning and memory
and general brain function. This work has advanced the field by screening for novel
regulators of synaptic development and uncovering a novel pathway necessary for
synaptic target selection.
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Appendix I.

Electron Microscopic analysis of autophagosomal development in Ema mutants

This work appears in the manuscript:
Kim S, Naylor SA, DiAntonio A. Ema promotes autophagosomal growth via Golgi
membrane trafficking. Developmental Cell (In Revision)
SAN performed electron microscopy, quantification and data analysis.
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Autophagy is a cellular process of self-digestion during which cytosolic
components are engulfed in double membrane autophagosomes and digested by
lysosomal acidic hydrolases (C. He and Klionsky 2009). While many genes are known to
be conserved in the formation, maturation and fusion of autophagosomes, there are still
many processes such as regulation of the size of autophagosomes, that remain to be
described. Our lab previously described a novel gene Ema that promotes endosomal
maturation. We hypothesized that ema may also play a role in autophagosomal
maturation.
To investigate Ema’s role in autophagy we took advantage of the Drosophila fat
body whose cells undergo extensive autophagy in response to starvation stimuli. While
many antibodies and transgenic fluorescently tagged molecules are available to
investigate autophagy in flies, to definitively determine autophagosome number and size
electron microscopy (EM) is necessary. I contributed to this project by performing
transmission EM on fed and starved fat body cells from wild type and ema mutant
drosophila larvae.

Methods
For ultrastructural analysis of the Drosophila fat cells, samples were fixed in 2%
paraformaldehyde/2.5% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM
phosphate buffer, pH 7.2 overnight at 4°C. Samples were washed in phosphate buffer
and postfixed in 0.5% osmium tetroxide (Polysciences Inc., Warrington, PA)/0.08%
potassium ferricyanide (Electron Microscopy Sciences, Fort Washington, PA)/100 mM
phosphate buffer for 1 hr at room temperature, and subsequently in 1% tannic acid
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(Electron Microscopy Sciences, Fort Washington, PA)/100 mM phosphate buffer for 1
hr. Samples were then rinsed extensively in dH20 prior to en bloc staining with 1%
aqueous uranyl acetate (Ted Pella Inc., Redding, CA) for 1 hr. Following several rinses
in dH20, samples were dehydrated in a graded series of ethanol and embedded in Eponate
12 resin (Ted Pella Inc.). Sections of 95 nm were cut with a Leica Ultracut UCT
ultramicrotome (Leica Microsystems Inc., Bannockburn, IL), stained with uranyl acetate
and lead citrate, and viewed on a JEOL 1200 EX transmission electron microscope
(JEOL USA Inc., Peabody, MA). Electron micrographs were also taken on a transmission
electron microscope (H-7500; Hitashi). For the analysis of the size of autophagic
structures, one image per section from wild type (n=8) and mutant (n=12) cells were
taken randomly at a magnification of 10,000X. The length along the longest axis of
autophagic structures was measured using imageJ.
Results
From our EM analysis, we found that both wild type and ema mutant fat cells contain
lipid droplets, glycogen deposits, membrane tubules, and cellular organelles including
mitochondria and ER (Fig A). Consistent with other markers tested in these fat cells, very
few profiles that could be endosomes or lysosomes could be detected under fed
conditions. Upon starvation, wild type fat cells exhibit extensive vesicular and vacuolar
autophagic structures, many containing remnants of mitochondria, ER and glycogen
particles (arrows Fig B). However, in the starved ema mutant fat cells, autophagosomes
are present but are significantly smaller than those in wild type. To quantify this we
measured the length of autophagic structures along their longest axes. Histogram and
cumulative probability plots illustrate that autophagic structures rarely reach 5 µm in
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length in the ema mutant but can reach sizes up to 10 µm in wild type (Fig D &E). On
average, autophagic structures in ema mutants are approximately two times smaller than
wild type (Fig C). This change in length suggests an approximately eight-fold decrease in
autophagosome volume. This EM data corroborates our light level data indicating that
ema mutants have significantly smaller autophagosomes.
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Figure AI-1.
(A) Transmission electron micrograph of fed Drosophila fat cells. Scale bars = 2 µm. (B) Transmission electron micrgraph of starved Drosophila fat cells. Autophagic structures (arrows) contain
many remnants of rough ER and mitochondria. Scale bars= 2 µm. (C) Histogram of quantification
of the length of autophagic structures in wild type and ema mutant fat cells n = 219 autophagic
structures from 8 sections from wild type; n = 326 from 12 sections from ema mutant.Error bars
represent SEM. t-test; *** (p<0.001)(D and E) Histogram (D) and cumulative probability plot (E) of
the length distribution of autophagic structures in starved fat cells.

Appendix II.

Electron Microscopic analysis of Taxol-induced neurodegeneration

This work appears in the manuscript:
Bhattacharya, M.R.C., Gerdts, J., Naylor, S.A., Royse, E., Ebstein, S.Y., Sasaki, Y.,
Milbrandt, J., DiAntonio, A., A model of toxic neuropathy in Drosophila reveals a
requirement for MORN4 in executing axonal degeneration. Journal of Neuroscience (In
Revision)

SAN performed electron microscopy, quantification and data analysis.
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Chemotherapeutic drugs have greatly advanced the treatment of many types of
cancer. Despite their great value in fighting cancer, these drugs are still associated with
dose-limiting and debilitating side effects including peripheral neuropathy. Our lab is
investigating the molecular mechanisms responsible for axon degeneration in response to
chemotherapeutic agents. A post-doc in the lab has developed an assay to deliver a
chemotherapy agent, Taxol, to developing drosophila larvae through their food. These
larvae can then be dissected and axonal degeneration can be observed. This model serves
as a powerful genetic tool to understand axonal degeneration.
In order to pursue studies to find genes and treatments that abrogate axonal
degeneration, we first had to establish the metrics of axonal degeneration in the
drosophila larval nerves. While changes in a genetically encoded GFP that labels class
IV sensory neurons can be observed at the light level (Figure A-C), electron microscopy
is necessary to ascertain that these nerves are degenerating in response to Taxol. I
contributed to this project by performing TEM analysis on vehicle and Taxol treated
larval nerves.

Methods
For ultrastructural analysis of the Drosophila nerves, samples were fixed in 2%
paraformaldehyde/2.5% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM
phosphate buffer, pH 7.2 overnight at 4°C. Samples were washed in phosphate buffer
and postfixed in 0.5% osmium tetroxide (Polysciences Inc., Warrington, PA)/0.08%
potassium ferricyanide (Electron Microscopy Sciences, Fort Washington, PA)/100 mM
phosphate buffer for 1 hr, and subsequently in 1% tannic acid (Electron Microscopy
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Sciences, Fort Washington, PA)/100 mM phosphate buffer for 1 hr. Samples were then
rinsed extensively in dH20 prior to en bloc staining with 1% aqueous uranyl acetate (Ted
Pella Inc., Redding, CA) for 1 hr. Following several rinses in dH20, samples were
dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella
Inc.). Sections of 100 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica
Microsystems Inc., Bannockburn, IL), stained with uranyl acetate and lead citrate.
Electron micrographs were taken on a transmission electron microscope (H-7500;
Hitashi). Quantification of axon number was performed on 10 non-consecutive sections
of nerves from at least three independent larvae per treatment condition. Statistical
analysis was performing using Student’s t-test with two tails.

Results
EM analysis of vehicle and taxol treated nerves revealed a striking loss of axons in the
taxol condition. There is an approximately two-fold decrease in the number of axons per
nerve after taxol treatment. Nerves of taxol-treated animals do not exhibit the tight
packing of axons found in vehicle treated nerves. There are large gaps that often contain
debris including organelles such as mitochondria, from the degenerating axons that once
filled the nerve. These data indicate that the response to taxol in our Drosophila model is
comparable to observed responses in mammals.
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Figure AII-1. Taxol exposure leads to axon loss in Drosophila larval nerves
A) Transmission electron micrograph of vehicle (DMSO) treated drosophila larval
nerve cross-section. Axons are tightly packed with little empty space within the nerve.
Scale bar 1 micron. B) Transmission electron micrograph of30 mM Taxol treated
drosophila larval nerve cross section. There is a significant loss of axons and an
increase in empty space within the nerve. Scale bar 1 micron C&D) Higher
magnification of vehicle and Taxol treated drosophila larval nerve cross sections.
These images indicate that the remaining nerves appear to be intact.Scale bar 200nm
E) Histogram shows quantification of number of axons per nerve in vehicle or Taxol
treatment. Taxol treatment causes a significant loss of axons. (Vehicle 80.9 ±3.9 n=10,
Taxol 42.7±5.1 n=10 p<.0001) Error bars represent SEM.
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